High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers

Cancer

Volumn 109, Issue 7, 2007, Pages 1360-1364

  Wang, Feng ^a   Xu, Rui Hua ^a   Han, Bing ^a   Shi, Yan Xia ^a   Luo, Hui Yan ^a   Jiang, Wen Qi ^a   Lin, Tong Yu ^a   Huang, Hui Qiang ^a   Xia, Zhong Jun ^a   Guan, Zhong Zhen ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Hepatitis B surface antigen; Hepatitis B virus; High incidence; Non Hodgkin lymphoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD SAMPLING; CANCER PATIENT; CHINESE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NONHUMAN; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INCIDENCE; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PREVALENCE;

EID: 33947522705     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22549     Document Type: Article

References (24)

1. Muller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:1-12.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
3. Berger F, Delecluse HJ. Lymphomas in immunocompromised host. Rev Pract. 1993;43:1661-1664.
4. de The G. Viruses and human cancers: challenges for preventive strategies. Environ Health Perspect. 1995;103:269-273.
5. Richard A. Infection and lymphoma. N Engl J Med. 2003; 349:1306-1311.
6. Bonnet F, Jouvencel AC, Parrens M, et al. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. J Clin Virol. 2006;36:258-263.
7. Pagano JS. Viruses and lymphomas. N Engl J Med. 2002; 347:78-79.
8. Cucuianu A, Patiu M, Duma M, et al. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol. 1999;107:353-356.
9. Seve P, Renaudier P, Sasco AJ, et al. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France. Eur J Gastroenterol Hepatol. 2004;16: 1361-1365.
10. Cucuianu A, Patiu M, Duma M, et al. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol. 1999;107:353-356.
11. Besson C, Canioni D, Lepage E, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH93 and LNH98 Groupe d'Etude des Lymphomas del'Adulte programs. J Clin Oncol. 2006;24:953-960.
12. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med. 2004;350:213-215.
13. Guidoboni M, Ferreri AJ, Ponzoni M, et al. Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives. Clin Lymphoma Myeloma. 2006;6:289-300.
14. Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology. 2005;37:409-419.
15. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337:1733-1745.
16. Li YH, He YF, Jiang WQ, et al. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma. Cancer. 2006;106:1320-1325.
17. Zhang JY, Dai M, Wang X, et al. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol. 1998;27:574-578.
18. He H, Zhai M, Zhang D, et al. Clinical significance of detecting serum label of hepatitis B virus in NHL patients. J Chinese Clin Med. 2003;4:8-10.
19. Kuniyoshi M, Nakamuta M, Sakai H, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol. 2001;16:215-219.
20. Kim JH, Bang YJ, Park BJ, et al. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res. 2002;93: 471-477.
21. Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica. 2006;91:554-557.
22. Huang CF, Lin SS, Ho YC, et al. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol. 2006;3:97-106.
23. Dewantoro O, Gani RA, Akbar N. Hepatocarcinogenesis in viral hepatitis B infection: the role of HBx and p53. Acta Med Indones. 2006;38:154-159.
24. Leung N. HBV and liver cancer. Med J Malaysia. 2005;60: 63-66.